Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
1,062.401,064.141,071.991,061.02
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
606.74606.74609.84602.33
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
1,238.211,236.601,247.741,232.10
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
1,718.611,723.231,741.481,717.47
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
637.37638.27642.30638.27
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
853.59854.05858.19851.34
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
218.33218.33219.73217.15
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
3,594.813,620.103,657.473,615.34
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
908.54909.50917.35907.07
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
1,495.001,499.611,517.101,499.61
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
2,398.312,406.822,421.802,404.22
4883:TYO
Modalis Therapeutics Corp
¥59.00
0.00%
(0.00) 1D
May 22, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4883...
Open
¥58
High
¥60
Low
¥57
Mkt. cap
5.68B
Avg. vol.
5.50M
Volume
1.16M
52-wk high
¥119
52-wk low
¥52
EPS
-¥28
No. of employees
17
News stories
From sources across the web
About Modalis Therapeutics Corp
CEOHaru Morita
Employees17
FoundedJan 14, 2016
Headquarters-
SectorBiotechnology
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
334.39M
726.27M
346.41M
293.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63.73M
56.81M
24.56M
49.00M
Operating expense
398.12M
783.08M
395.97M
342.00M
Total operating expenses
398.12M
783.08M
395.97M
342.00M
Operating income
-398.12M
-783.08M
-395.97M
-342.00M
Other non operating income
46.10M
-2.52M
11.62M
5.00M
EBT including unusual items
-368.22M
-780.69M
-350.53M
-323.00M
EBT excluding unusual items
-368.22M
-779.04M
-350.77M
-323.00M
Income tax expense
-435.00K
625.00K
-300.00K
-
Effective tax rate
0.12%
-0.08%
0.09%
-
Other operating expenses
-
-
25.00M
-
Net income
-367.79M
-781.32M
-350.23M
-323.00M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
2.53M
439.00K
2.00M
Interest expense
-480.00K
-7.92M
-839.00K
-2.00M
Net interest expenses
-480.00K
-5.39M
-400.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-397.82M
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more